Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health,Aging and Body Composition Study

Abstract

Background:

Medication complexity is a large determinant of adherence. Few studies have explored the relationship between cognitive impairment and medication complexity.

Objective:

To evaluate whether cognitive impairment is associated with medication complexity for prescription and over-the-counter (OTC) medications.

Methods:

In this cross-sectional analysis, we studied the association between cognitive impairment and the complexity of prescription and OTC drug regimens. Baseline participants were from the Health, Aging and Body Composition study, consisting of 3075 well-functioning 70- to 79-year-old black and white men and women. Cognitive impairment was defined by having a Modified Mini-Mental State Examination score <80. The complexity of prescription and OTC (including supplements/herbals) medications was assessed using a modified version of the Medication Regimen Complexity Index (mMRCI). The mMRCI score increases with complexity of dosage forms, number of medications, pill burden, and nondaily dosing.

Results:

The mean (SD) age was 74 (2.9) years (n = 3055; 52% female, 41% black). The median prescription mMRCI score was 6 (range 0–66). The median OTC mMRCI score was 4 (range 0–71). Adjusting for health status, demographics, and access to care, medication complexity was lower in participants with cognitive impairment for prescription (adjusted RR 0.89; 95% CI 0.80 to 0.99) and OTC medications (adjusted RR 0.76; 95% CI 0.64 to 0.93) compared to those without cognitive impairment. The number of prescription medications was not different, but the number of OTC drugs was lower for those with cognitive impairment.

Conclusions:

In this cohort of well-functioning older adults, those with cognitive impairment had lower prescription complexity due to less-complex dosage forms, pill burden, or daily dosing. OTC complexity was also lower, primarily due to a lower number of OTC drugs. The results of this study show that further research on medication complexity and adherence and health outcomes in cognitively impaired individuals is warranted.

Get full access to this article

View all access options for this article.

References

Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization. 2003.

Ingersoll

Cohen

. The impact of medication regimen factors on adherence to chronic treatment: A review of literature. J Behav Med 2008; 31: 213–24. doi: 10.1007/s10865-007-9147-y

Osterberg

Blaschke

. Adherence to medication. N Engl J Med 2005; 353: 487–97. doi: 10.1056/NEJMra050100

Conn

Taylor

Kelley

. Medication regimen complexity and adherence among older adults. Image J Nurs Sch 1991; 23: 231–5. doi: 10.1111/j.1547–5069.1991.tb00677.x

Choudhry

Fischer

Avorn

. The Implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med 2011; 171: 814–22. doi: 10.1001/archinternmed.2010.495

Ownby

. Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults. Geriatrics 2006; 61: 30–5.

Teng

Chui

. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314–8.

Bland

. Mild dementia or cognitive impairment: The Modified Mini-Mental State Examination (3MS) as a screen for dementia. Can J Psychiatry 2001; 46: 506.

Rooks

Simonsick

Miles

. The association of race and socioeconomic status with cardiovascular disease indicators among older adults in the Health, Aging, and Body Composition Study. J Gerontol B Psychol Sci Soc Sci 2002; 57: S247–56. doi: 10.1093/geronb/57.4.S247

10.

Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32 (suppl 1): S62–7.

11.

Radloff

. The CES-D scale. Applied Psychological Measurement 1977; 1: 385–401. doi: 10.1177/014662167700100306

12.

Butler

Kalogeropoulos

Georgiopoulou

. Incident heart failure prediction in the elderly: The Health ABC heart failure score. Circ Heart Fail 2008; 1: 125–33. doi: CIRCHEARTFAILURE.108.768457

13.

Smith

Psaty

Heckbert

Tracy

Cornell

. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999; 52: 143–6. doi: 10.1016/j.bbr.2011.03.031

14.

Caskie

Willis

Schaie

Warner K

Zanjani

. Congruence of medication information from a brown bag data collection and pharmacy records: Findings from the Seattle Longitudinal Study. Exp Aging Res 2006; 32: 79–103. doi: 10.1080/03610730500326341

15.

Pit

Byles

Cockburn

. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging 2008; 25: 71–80.

16.

George

Phun

Y-T

Bailey

Kong

DCM

Stewart

. Development and validation of the medication regimen complexity index. Ann Pharmacother 2004; 38: 1369–76. doi: 10.1345/aph.1D479

17.

George

Vuong

Bailey

Kong

Marriott

Stewart

. Regimen complexity and medication adherence in patients at risk of medication misadventure. J Pharm Pract Res 2006; 36: 99–102.

18.

Schmader

Hanlon

Fillenbaum

Huber

Pieper

Horner

. Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing 1998; 27: 493–501. doi: 10.1093/ageing/27.4.493

19.

Crentsil

Ricks

Xue

Fried

. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use. Am J Geriatr Pharmacother 2010; 8: 215–24. doi: 10.1016/j.amjopharm.2010.06.003

20.

Hanlon

Landerman

Wall

Jr . Is medication use by community-dwelling elderly people influenced by cognitive function? Age Ageing 1996; 25: 190–6. doi: 10.1093/ageing/25.3.190

21.

Payne

Neutel

Cho

DesMeules

. Factors associated with women's medication use. BMC Womens Health 2004; 4: S29. doi:10.1186/472-6874-4–S1-S29

22.

Hanlon

Fillenbaum

Burchett

. Drug-use patterns among black and nonblack community-dwelling elderly. Ann Pharmacother 1992; 26: 679–85.